policy
Six disciplines of KAIST have emerged among the top 20 in the world. The 2017 QS World University Rankings by Subject rated Materials Science at KAIST 13th in the global ranking. Other subjects ranked within top 20 include Chemical and Biomolecular Engineering (15th), Civil and Environmental Engineering (15th), Mechanical and Aerospace Engineering (15th), Electrical Engineering (17th), and Chemistry (18th). This year, two more disciplines advanced into the top 20 from four in 2016.
QS ranked KAIST as the top science and technology research university in Korea. KAIST earned the highest global rankings among Korean universities in the following seven areas: Materials Science and Engineering (13th), Chemical and Biomolecular Engineering (15th), Civil and Environmental Engineering (15th), Mechanical and Aerospace Engineering (15th), Electrical Engineering (17th), Chemistry (18th), and the School of Computing (33th). In addition, two more disciplines of Physics (44th) and Mathematical Sciences (47th) were ranked second among domestic universities.
The London-based university ranking by Quacquarelli Symonds, Ltd. announced the global university ranking by 46 subjects on March 8. QS rankings are based on academic reputation, employer reputation, the number of research citations, and research accomplishment index (H-index).
-
research Editing Parkinson's Disease – KAIST Makes World's First Discovery of an Inflammatory RNA Editing Enzyme
< Professor Minee Choi of the Department of Brain and Cognitive Sciences (top left). Professor Sonia Gandhi (top right) and Professor Klenerman of the University College London (bottom right) > Parkinson's disease (PD) is a neurodegenerative disorder in which the α-synuclein protein abnormally aggregates within brain cells, causing neuronal damage. Through international collaboration, researchers at KAIST have revealed that RNA editing plays a crucial role in regulating neuroi
2025-05-02 -
event KAIST Art Museum Showcases the Works of Van Gogh, Cy Twombly, and More at "The Vault of Masterpieces"
KAIST (President Kwang Hyung Lee) opened a special exhibition "The Vault of Masterpieces" featuring the architects of the Gallerist Hong Gyu Shin, who is active in New York, on April 29th. Since its opening in December 2024, the KAIST Museum of Art, which has mainly exhibited works from its own collection, has boldly invited internationally renowned gallerist Shin Hong-gyu to hold its first full-scale special exhibition, displaying a large number of his collections in the center of the campus
2025-04-30 -
research KAIST sends out Music and Bio-Signs of Professor Kwon Ji-yong, a.k.a. G-Dragon, into Space to Pulsate through Universe and Resonate among Stars
KAIST (President Kwang-Hyung Lee) announced on the 10th of April that it successfully promoted the world’s first ‘Space Sound Source Transmission Project’ based on media art at the KAIST Space Research Institute on April 9th through collaboration between Professor Jinjoon Lee of the Graduate School of Culture Technology, a world-renowned media artist, and the global K-Pop artist, G-Dragon. This project was proposed as part of the ‘AI Entertech Research Center’ be
2025-04-10 -
event KAIST, Galaxy Corporation Hold Signboard Ceremony for ‘AI Entertech Research Center’
KAIST (President Kwang-Hyung Lee) announced on the 9th that it will hold a signboard ceremony for the establishment of the ‘AI Entertech Research Center’ with the artificial intelligence entertech company, Galaxy Corporation (CEO Yong-ho Choi) at the main campus of KAIST. < (Galaxy Corporation, from center to the left) CEO Yongho Choi, Director Hyunjung Kim and related persons / (KAIST, from center to the right) Professor SeungSeob Lee of the Department of Mechanical Engineer
2025-04-09 -
research KAIST Identifies Master Regulator Blocking Immunotherapy, Paving the Way for a New Lung Cancer Treatment
Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to these treatments, highlighting the urgent need for new strategies tailored to both responders and non-responders. KAIST researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy—opening
2025-04-08